Stephon D. Tillis
FDA investigator
Appears on 1 document from 2024, mostly at sites in California. Most often cites testing and approval or rejection of components, drug product containers, and closures (21 CFR 211.84(d)(1)).
- 1
- Documents on file
- 6.0
- Observations per 483
- 2024
- First seen
- 2024
- Most recent
What they cite most
From 6 observations- 21 CFR 211.84(d)(1)Testing and approval or rejection of components, drug product containers, and closures2
- 21 CFR 211.100(a)Written procedures; deviations1
- 21 CFR 211.166(a)Stability testing1
- 21 CFR 211.192Production record review1
- 21 CFR 211.68(b)Automatic, mechanical, and electronic equipment1
Activity by year
2024: 1
Where
California 1
Often inspects with
Is Stephon D. Tillis coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2024-10-31 | 483 Westwood Laboratories, LLCOct 31, 2024 · Azusa, California | Azusa, California | 6 |
About this profile
What does Stephon D. Tillis inspect?
Stephon D. Tillis appears on 1 document on file covering 1 site, mostly in California.
What do they cite most often?
21 CFR 211.84(d)(1) (testing and approval or rejection of components, drug product containers, and closures), followed by 21 CFR 211.100(a) and 21 CFR 211.166(a).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Stephon D. Tillis is dated Oct 31, 2024.